Last updated at 16 Nov 2025 02:13 PM
Director
DIN: 08036816
Sridevi Bommena . is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at BLUESTRIDES FINANCIAL SERVICES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08036816.Sridevi Bommena . is currently involved in 2 different roles. Their most recent position is with ACCESS BIOPHARMA PRIVATE LIMITED as a Director. The first company Sridevi Bommena . was appointed to as a director was BLUESTRIDES FINANCIAL SERVICES PRIVATE LIMITED. Sridevi Bommena . is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sridevi Bommena . is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at BLUESTRIDES FINANCIAL SERVICES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08036816.Sridevi Bommena . is currently involved in 2 different roles. Their most recent position is with ACCESS BIOPHARMA PRIVATE LIMITED as a Director. The first company Sridevi Bommena . was appointed to as a director was BLUESTRIDES FINANCIAL SERVICES PRIVATE LIMITED. Sridevi Bommena . is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 7m 10 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| BLUESTRIDES FINANCIAL SERVICES PRIVATE LIMITED | Director | 12-Mar-2018 |
| BLUESTRIDES FINANCIAL SERVICES PRIVATE LIMITED | Individual Promoter | 12-Mar-2018 |
| ACCESS BIOPHARMA PRIVATE LIMITED | Director | 03-Jun-2025 |